24 LIfesciences trend

  According to a newly published market research report by 24LifeSciences , global hydroxyethyl starch injection market was valued at USD 450 million in 2025 and is projected to reach USD 680 million by 2034 , growing at a compound annual growth rate (CAGR) of 4.7% during the forecast period 20262034 . Hydroxyethyl Starch (HES) Injection, a colloidal plasma volume expander derived from natural polysaccharides, is clinically used for fluid resuscitation in hypovolemia during surgeries, trauma cases, and critical care . The market offers various formulations including Hydroxyethyl Starch 130/0.4, 200/0.5, and 40 Sodium Chloride Injection , with the 130/0.4 variant currently holding over 60% market share due to its improved safety profile and controlled molecular weight distribution. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15246/hydroxyethyl-starch-injection-market Increasing Surgical Volumes and Trauma Cases Drive Market Growth The growi...

 According to a newly published market research report by 24LifeSciences , global RAS-acting Agents market was valued at USD 2.8 billion in 2025 and is projected to reach USD 4.5 billion by 2034 , growing at a compound annual growth rate (CAGR) of 5.2% during the forecast period 2026–2034 . RAS-acting Agents are pharmaceutical compounds targeting the renin-angiotensin system, crucial for regulating blood pressure and cardiovascular function. These agents include ACE inhibitors, ARBs, renin inhibitors, and aldosterone antagonists , widely prescribed for conditions like hypertension, heart failure, and diabetic nephropathy. Their clinical importance stems from proven effectiveness in reducing cardiovascular mortality and renal disease progression. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15462/ras-acting-agents-market Escalating Global Hypertension Burden Drives Sustained Market Growth The market's primary growth engine is the rising prev...

 According to a newly published market research report by 24LifeSciences , global organ transplant rejection medicine market was valued at USD 2.34 billion in 2025 and is projected to reach USD 4.18 billion by 2034 , growing at a compound annual growth rate (CAGR) of 6.7% during the forecast period 20262034 . Organ transplant rejection medicines are specialized pharmaceutical agents designed to prevent or treat rejection of transplanted organs by suppressing the recipient's immune response. These medications primarily include calcineurin inhibitors , mTOR inhibitors , antiproliferative agents , steroids , and monoclonal antibodies , each working through distinct mechanisms to protect transplanted organs from immune system attacks while improving graft survival rates. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15222/organ-transplant-rejection-medicine-market Growing Transplant Volumes and Chronic Diseases Drive Market Expansion The steady ...

 According to a newly published market research report by 24LifeSciences , global vaccine administration devices market was valued at USD 5.3 billion in 2023 and is projected to reach USD 8.1 billion by 2030 , growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period 20242030 . Vaccine administration devices encompass syringes, jet injectors, microneedle patches, and intranasal delivery systems that enable safe and effective vaccine delivery through various routes including intramuscular, subcutaneous, and intradermal methods. The market has gained substantial momentum post-COVID-19, with needle-free technologies emerging as a critical innovation area to improve vaccination compliance and minimize needlestick injuries. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15336/vaccine-administration-devices-market Global Immunization Initiatives Drive Market Expansion The growing emphasis on vaccination programs worldwide...

 According to a newly published market research report by 24LifeSciences , global High Intensity Focused Ultrasound (HIFU) facial care equipment market was valued at USD 380.5 million in 2024 and is projected to reach USD 720.8 million by 2032 , growing at a compound annual growth rate (CAGR) of 8.3% during the forecast period 20252032 . High Intensity Focused Ultrasound facial care equipment utilizes precise ultrasonic energy to stimulate collagen production in the deeper layers of skin without invasive procedures. These devices deliver focused thermal energy to subcutaneous tissues at temperatures between 60-70C , triggering natural healing responses that tighten skin, reduce wrinkles, and improve facial contours. The technology has gained significant traction as a non-surgical alternative to traditional facelifts and other anti-aging treatments. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/13920/high-intensity-focused-ultrasound-facial-...

  According to a newly published market research report by 24LifeSciences , global cosmetic surgical surgery and procedure market was valued at USD 10.2 billion in 2024 and is projected to reach USD 21.8 billion by 2031 , growing at a compound annual growth rate (CAGR) of 9.8% during the forecast period 2025-2031 . Cosmetic surgical procedures are medical operations performed to reshape normal structures of the body to improve appearance and self-esteem. They include breast augmentation, liposuction, nose reshaping, eyelid surgery, tummy tucks and other aesthetic enhancements. While elective in nature, these procedures require surgical expertise similar to reconstructive operations and carry comparable medical risks. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15743/cosmetic-surgical-surgery-and-procedure-market Increasing Beauty Consciousness and Social Media Influence Drive Market Growth The rising influence of social media platforms a...

  According to a newly published market research report by 24LifeSciences , global Bio-MEMS & Microfluidics market was valued at USD 4.8 billion in 2024 and is projected to reach USD 12.3 billion by 2031 , growing at a compound annual growth rate (CAGR) of 14.2% during the forecast period 2025-2031 . Bio-MEMS (Biological Micro-Electro-Mechanical Systems) and microfluidics represent cutting-edge interdisciplinary technologies that combine biological applications with micro-scale mechanical and electrical systems. These innovations enable precise manipulation of fluids at microscale levels, revolutionizing medical diagnostics, drug delivery, and research methodologies. Their lab-on-a-chip capabilities have transformed point-of-care testing, while implantable Bio-MEMS devices are advancing chronic disease management through continuous monitoring. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15639/bio-mems-microfluidics-market Minimally In...

 According to a newly published market research report by 24LifeSciences , global CD25 (IL2R alpha) ELISA Kit market was valued at USD 10.7 million in 2024 and is projected to reach USD 17.5 million by 2031 , growing at a compound annual growth rate (CAGR) of 7.5% during the forecast period 2025–2031 . The CD25 (IL2R alpha) ELISA Kit is a critical diagnostic tool used to quantify CD25 protein concentrations in biological samples. CD25 serves as the alpha chain of the interleukin-2 receptor (IL-2R), playing a pivotal role in T-cell activation and immune system regulation. These kits utilize specific antibodies to capture CD25 proteins, followed by colorimetric detection for precise measurement. Their applications span immunology research, autoimmune disease studies, and clinical diagnostics, particularly in monitoring conditions like graft-versus-host disease and certain cancers. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/2969/cd-ilr-alpha...

  According to a newly published market research report by 24LifeSciences , global Cardiotomy Renous Reservoir market was valued at USD 299 million in 2024 and is projected to grow from USD 318 million in 2025 to USD 453 million by 2031 , growing at a compound annual growth rate (CAGR) of 6.2% during the forecast period. Cardiotomy Renous Reservoirs are specialized cardiopulmonary bypass devices used in cardiac surgery to collect, filter, and store blood drawn during procedures. These devices typically feature polycarbonate construction with integrated safety valves, volumetric scales, and multi-layer filtration systems using materials like polyester mesh to effectively remove air emboli from the blood circuit. The growing adoption of vacuum-assisted drainage systems in cardiac surgeries is a key factor driving market expansion. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/4908/cardiotomy-renous-reservoir-market Market Growth Driven by Inc...

 According to a newly published market research report by 24LifeSciences , global hematologic malignancies market was valued at USD 29.3 billion in 2024 and is projected to reach USD 52.8 billion by 2031 , growing at a compound annual growth rate (CAGR) of 7.4% during the forecast period 20252031 . Hematologic malignancies encompass a group of cancers affecting the blood, bone marrow, and lymphatic system, including leukemia, lymphoma (both Hodgkin and non-Hodgkin), and multiple myeloma . These conditions are characterized by abnormal proliferation of white blood cells and represent some of the most complex cancer types to diagnose and treat. Recent breakthroughs in immunotherapy, targeted therapies, and precision medicine are revolutionizing treatment approaches and improving patient outcomes. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/15768/hematologic-malignancies-market Rising Global Cancer Burden Drives Market Expansion The increasi...